Abstract:Background: Murine polyomavirus recognizes (alpha2,3)-linked alpha-5-N-acetylneuraminic acid (sialic acid) on the surface of susceptible cells. While all strains bind to straight-chain receptors terminating in (alpha2,3)-linked sialic acid, some strains also bind to branched oligosaccharides that carry a second, (alpha2,6)-linked sialic acid. The ability to bind to these branched-chain receptors correlates with a single amino acid mutation at position 91 on the outer surface of the major capsid protein, VP1, and with a significant decrease in tumorigenicity. Results: We have determined the structures of polyomavirus strain P16, which bears a glycine at position 91, in complex with model compounds for both straight-chain and branched-chain sialoglycoconjugates. The structures have been refined to a resolution of 3.65 degree. The ligands bind to a shallow groove on the surface of VP1. The sialic acid-(alpha2,3)-galactose moiety, which is common to both compounds, has specific and identical contacts. The additional (alpha2,6)-linked sialic acid moiety of the branched-chain receptor fragment fits into a surface pocket, but it has high thermal factors and does not form hydrogen bonds to groups on VP1. Data collected from crystals soaked at different oligosaccharide concentrations establish that both receptor fragments have similar, low affinities (dissociation constants in the range 5-10 mM) for the P16 virus, consistent with the interactions seen in the two complexes. Conclusion: The oligosaccharide-binding groove is complementary to the shape of the bound glycan, but there are relatively few hydrogen bonds between glycan and protein. Thus, the nature of the glycosidic linkages appears to be the principal determinant of specificity, rather than the position of particular hydroxyl groups. The low receptor affinity may be important for avoiding inhibition of viral release by retention on surface receptors of infected cells. Evidence suggests that strains with still greater pathogenicity are likely to have even weaker affinity.

Glycan binding avidity determines the systemic fate of adeno-2 associated virus 9 3 4 5

Glycan Binding Avidity Determines the Systemic Fate of Adeno-Associated Virus Type 9

Site-Specific N-Glycosylation on the AAV8 Capsid Protein.

Unique glycan signatures regulate adeno-associated virus tropism in the developing brain

The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice

AAV6 K531 serves a dual function in selective receptor and antibody ADK6 recognition

A Comprehensive Atlas of AAV Tropism in the Mouse

Differences In Affinity Of Binding Of Lymphocytic Choriomeningitis Virus Strains To The Cellular Receptor Alpha-Dystroglycan Correlate With Viral Tropism And Disease Kinetics

Gene therapy vectors based on adeno-associated virus type 1

Structure of neurotropic adeno-associated virus AAVrh.8

Adeno-associated Virus (AAV) versus Immune Response

Identification of SLC35A1 as an essential host factor for the transduction of multi-serotype recombinant adeno-associated virus (AAV) vectors

N-terminal serine/threonine motif has diverse and important effects on behavior of multiple AAV serotypes

Innate Immune Sensing of Adeno-Associated Virus Vectors

Site-specific modification of adeno-associated viruses via a genetically engineered aldehyde tag.

Therapeutic Application and Structural Features of Adeno-Associated Virus Vector

Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid

Receptor Switching in Newly Evolved Adeno-associated Viruses

Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors

Structural Characterization of a Novel Human Adeno-Associated Virus Capsid with Neurotropic Properties

Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments